CA
CATX icon

Cetera Advisors’s Perspective Therapeutics CATX Stock Holding History

Cetera Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$14.9K Buy
+1,250
New +$10.7K ﹤0.01% 2403

Other funds holding CATX

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.35B AUM 17.18% 1-Year Est. Return

Cetera Advisors's CATX Position: Q1 2024 in Review

Cetera Advisors opened a new position in Perspective Therapeutics (CATX) in Q1 2024: 1,250 shares worth $14.9K. The stake represents ﹤0.01% of the portfolio and ranks #2403 among its holdings.

103 funds tracked by Wall St. Rank hold CATX as of Q1 2024.

  • Cetera Advisors held 1,250 shares of Perspective Therapeutics worth $14.9K as of Q1 2024.
  • Perspective Therapeutics was a new Cetera Advisors position in Q1 2024.
  • Perspective Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2403 holding.
  • 103 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.